{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:12:38Z","timestamp":1791317558764,"version":"4.3.1"},"reference-count":20,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Invadopodia are proteolytically active membrane protrusions that extend from the ventral surface of invasive tumoral cells grown on an extracellular matrix (ECM). The core machinery controlling invadopodia biogenesis is regulated by the Rho GTPase Cdc42. To understand the upstream events regulating invadopodia biogenesis, we investigated the role of Fgd1, a Cdc42-specific guanine nucleotide exchange factor. Loss of Fgd1 causes the rare inherited human developmental disease faciogenital dysplasia. Here, we show that Fgd1 is required for invadopodia biogenesis and ECM degradation in an invasive cell model and functions by modulation of Cdc42 activation. We also find that Fgd1 is expressed in human prostate and breast cancer as opposed to normal tissue and that expression levels matched tumor aggressiveness. Our findings suggest a central role for Fgd1 in the focal degradation of the ECM in vitro and, for the first time, show a connection between Fgd1 and cancer progression, proposing that it might function during tumorigenesis. [Cancer Res 2009;69(3):747\u201352]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-1980","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T21:00:28Z","timestamp":1231880428000},"page":"747-752","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Faciogenital Dysplasia Protein Fgd1 Regulates Invadopodia Biogenesis and Extracellular Matrix Degradation and Is Up-regulated in Prostate and Breast Cancer"],"prefix":"10.1158","volume":"69","author":[{"given":"Inmaculada","family":"Ayala","sequence":"first","affiliation":[{"name":"1Tumor Cell Invasion Laboratory,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Giacchetti","sequence":"additional","affiliation":[{"name":"1Tumor Cell Invasion Laboratory,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Caldieri","sequence":"additional","affiliation":[{"name":"1Tumor Cell Invasion Laboratory,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Attanasio","sequence":"additional","affiliation":[{"name":"1Tumor Cell Invasion Laboratory,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mariggio\u0300","sequence":"additional","affiliation":[{"name":"2Cell Regulation Laboratory, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tete\u0300","sequence":"additional","affiliation":[{"name":"4Department of Oral Sciences, University \u201cG. D'Annunzio\u201d, Chieti, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Polishchuk","sequence":"additional","affiliation":[{"name":"3Membrane Sorting and Biogenesis Unit, Department of Cell Biology and Oncology, Consorzio Mario Negri Sud, S. Maria Imbaro (Chieti), Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Castronovo","sequence":"additional","affiliation":[{"name":"5Metastases Research Laboratory, Giga-Cancer, University of Liege, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Buccione","sequence":"additional","affiliation":[{"name":"1Tumor Cell Invasion Laboratory,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"2022061701334841600_B1","doi-asserted-by":"crossref","unstructured":"Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol\u20082004; 5: 647\u201357.","DOI":"10.1038\/nrm1436"},{"key":"2022061701334841600_B2","doi-asserted-by":"crossref","unstructured":"Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis\u20082006; 23: 97\u2013105.","DOI":"10.1007\/s10585-006-9014-1"},{"key":"2022061701334841600_B3","doi-asserted-by":"crossref","unstructured":"Yamaguchi H, Lorenz M, Kempiak S, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2\/3 complex pathway and cofilin. J Cell Biol\u20082005; 168: 441\u201352.","DOI":"10.1083\/jcb.200407076"},{"key":"2022061701334841600_B4","doi-asserted-by":"crossref","unstructured":"Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J\u20082000; 348 Pt 2: 241\u201355.","DOI":"10.1042\/bj3480241"},{"key":"2022061701334841600_B5","doi-asserted-by":"crossref","unstructured":"Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev\u20082002; 16: 1587\u2013609.","DOI":"10.1101\/gad.1003302"},{"key":"2022061701334841600_B6","doi-asserted-by":"crossref","unstructured":"Zheng Y, Fischer DJ, Santos MF, et al. The faciogenital dysplasia gene product FGD1 functions as a Cdc42Hs-specific guanine-nucleotide exchange factor. J Biol Chem\u20081996; 271: 33169\u201372.","DOI":"10.1074\/jbc.271.52.33169"},{"key":"2022061701334841600_B7","doi-asserted-by":"crossref","unstructured":"Gorski JL, Estrada L, Hu C, Liu Z. Skeletal-specific expression of Fgd1 during bone formation and skeletal defects in faciogenital dysplasia (FGDY; Aarskog syndrome). Dev Dyn\u20082000; 218: 573\u201386.","DOI":"10.1002\/1097-0177(2000)9999:9999<::AID-DVDY1015>3.0.CO;2-F"},{"key":"2022061701334841600_B8","doi-asserted-by":"crossref","unstructured":"Hou P, Estrada L, Kinley AW, Parsons JT, Vojtek AB, Gorski JL. Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum Mol Genet\u20082003; 12: 1981\u201393.","DOI":"10.1093\/hmg\/ddg209"},{"key":"2022061701334841600_B9","doi-asserted-by":"crossref","unstructured":"Kim K, Hou P, Gorski JL, Cooper JA. Effect of Fgd1 on cortactin in Arp2\/3 complex-mediated actin assembly. Biochemistry\u20082004; 43: 2422\u20137.","DOI":"10.1021\/bi036173t"},{"key":"2022061701334841600_B10","doi-asserted-by":"crossref","unstructured":"Ayala I, Baldassarre M, Giacchetti G, et al. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 2008;121:369\u201378.","DOI":"10.1242\/jcs.008037"},{"key":"2022061701334841600_B11","doi-asserted-by":"crossref","unstructured":"Baldassarre M, Pompeo A, Beznoussenko G, et al. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell\u20082003; 14: 1074\u201384.","DOI":"10.1091\/mbc.e02-05-0308"},{"key":"2022061701334841600_B12","doi-asserted-by":"crossref","unstructured":"Usui I, Imamura T, Huang J, Satoh H, Olefsky JM. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-1 adipocytes. J Biol Chem\u20082003; 278: 13765\u201374.","DOI":"10.1074\/jbc.M208904200"},{"key":"2022061701334841600_B13","doi-asserted-by":"crossref","unstructured":"Bowden ET, Coopman PJ, Mueller SC. Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol\u20082001; 63: 613\u201327.","DOI":"10.1016\/S0091-679X(01)63033-4"},{"key":"2022061701334841600_B14","doi-asserted-by":"crossref","unstructured":"Nagata K, Driessens M, Lamarche N, Gorski JL, Hall A. Activation of G1 progression, JNK mitogen-activated protein kinase, and actin filament assembly by the exchange factor FGD1. J Biol Chem\u20081998; 273: 15453\u20137.","DOI":"10.1074\/jbc.273.25.15453"},{"key":"2022061701334841600_B15","doi-asserted-by":"crossref","unstructured":"Estrada L, Caron E, Gorski JL. Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane. Hum Mol Genet\u20082001; 10: 485\u201395.","DOI":"10.1093\/hmg\/10.5.485"},{"key":"2022061701334841600_B16","doi-asserted-by":"crossref","unstructured":"Brown PD. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv Enzyme Regul\u20081995; 35: 293\u2013301.","DOI":"10.1016\/0065-2571(94)00022-U"},{"key":"2022061701334841600_B17","doi-asserted-by":"crossref","unstructured":"Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res\u20082006; 66: 3034\u201343.","DOI":"10.1158\/0008-5472.CAN-05-2177"},{"key":"2022061701334841600_B18","doi-asserted-by":"crossref","unstructured":"Pasteris NG, Buckler J, Cadle AB, Gorski JL. Genomic organization of the faciogenital dysplasia (FGD1; Aarskog syndrome) gene. Genomics\u20081997; 43: 390\u20134.","DOI":"10.1006\/geno.1997.4837"},{"key":"2022061701334841600_B19","doi-asserted-by":"crossref","unstructured":"Pelish HE, Peterson JR, Salvarezza SB, et al. Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nat Chem Biol\u20082006; 2: 39\u201346.","DOI":"10.1038\/nchembio751"},{"key":"2022061701334841600_B20","doi-asserted-by":"crossref","unstructured":"Olson MF. Guanine nucleotide exchange factors for the Rho GTPases: a role in human disease? J Mol Med\u20081996; 74: 563\u201371.","DOI":"10.1007\/s001090050060"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/3\/747\/2621029\/747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/3\/747\/2621029\/747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:12:48Z","timestamp":1655435568000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/3\/747\/552783\/Faciogenital-Dysplasia-Protein-Fgd1-Regulates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,1,29]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-1980","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499845.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381368.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381359.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499845","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381356.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381365.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381362.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}